Skip to content

Continuous Intravenous Lidocaine Infusion for Preserving Postoperative Diaphragmatic Function in Laparoscopic Colorectal Cancer Surgery: A single-center, double-blind, randomized, controlled clinical trial

Continuous Intravenous Lidocaine Infusion for Preserving Postoperative Diaphragmatic Function in Laparoscopic Colorectal Cancer Surgery: A single-center, double-blind, randomized, controlled clinical trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099244
Enrollment
Unknown
Registered
2025-03-20
Start date
2025-01-03
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative diaphragmatic dysfunction

Interventions

Experimental group:Patients were administered with continuous intravenous lidocaine infusion from the start of anesthesia induction to 24 hours postoperatively, starting with intravenous lidocaine 1.5
Control group:The same volume of 0.9% normal saline was administered at the same infusion rate

Sponsors

The First People's Hospital of Foshan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective laparoscopic colorectal cancer surgery: 1.Age 45-80 years; 2.ASA Grading I-III; 3.Body mass index BMI <=30 kg /m^2; 4.Patients and their families voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Preoperative diaphragm-related diseases or neuromuscular related diseases; 2.History of previous thoracic and abdominal trauma and surgery; 3.Preoperative combined with severe cardiovascular, liver parenchymal damage (ALT or AST >2 times the normal value), renal failure (SCr>177 umol/L), respiratory failure; 4.Lidocaine allergy; 5.History of epilepsy; 6.Mental and psychological diseases, cognitive dysfunction; 7.Patient or family member refuses this study or refuses to undergo diaphragm or lung ultrasound.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative diaphragmatic dysfunction;

Secondary

MeasureTime frame
Diaphragmatic excursion;Pulmonary complications (including pulmonary infection, respiratory failure, atelectasis, pneumothorax, pleural effusion, bronchospasm, and aspiration pneumonia) within 7 days after surgery;Diaphragmatic thickening fraction ;Diaphragmatic rapid shallow breathing index;Diaphragmatic contraction velocity;

Countries

China

Contacts

Public ContactWanyou He

The First People's Hospital of Foshan

hewanyou1985@qq.com+86 180 3886 2159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026